Multi-drug-resistant tuberculosis history and symptoms

Jump to navigation Jump to search

Multi-drug-resistant tuberculosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multi-drug-resistant tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multi-drug-resistant tuberculosis history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multi-drug-resistant tuberculosis history and symptoms

CDC on Multi-drug-resistant tuberculosis history and symptoms

Multi-drug-resistant tuberculosis history and symptoms in the news

Blogs on Multi-drug-resistant tuberculosis history and symptoms

Directions to Hospitals Treating Multi-drug-resistant tuberculosis

Risk calculators and risk factors for Multi-drug-resistant tuberculosis history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

The general symptoms of MDR-TB will be the same as drug suceptible tuberculosis, these include weakness, weight loss, fever, and night sweats. Symptoms of pulmonary tuberculosis include cough, chest pain, and hemoptysis. Tuberculosis is particularly difficult to diagnose in children, as these may not present with common findings.

History

Clinicians should ask about the patient’s history of TB and MDR-TB exposure, infection, or disease. It is also important to consider demographic factors (e.g., country of origin, age, ethnic or racial group, occupation) that may increase the patient’s risk for exposure to drug-resistant TB. Also, clinicians should determine whether the patient has medical conditions, especially HIV infection, that increase the risk of latent TB infection progressing to TB disease.

Symptoms

When the disease becomes active, 75% of the cases are located in the lungs. Pulmonary tuberculosis should be suspected in persons who have the following symptoms:[1]

  • Cough (most common symptom)
  • Initially dry cough that progresses to productive.
  • Persistent cough, usually for more than three weeks.

Extra-Pulmonary Tuberculosis

In the other 25% of active cases, the infection moves from the lungs, causing other kinds of TB more common in immunosuppressed persons and young children.

An especially serious form is disseminated TB, more commonly known as miliary tuberculosis. Although extrapulmonary TB is not contagious, it may co-exist with pulmonary TB, which is contagious.[2]

All forms of extra-pulmonary tuberculosis can include symptoms of pulmonary tuberculosis such as malaise, night sweats, cough, weight loss, and can be associated with an active pulmonary infection.

Extra-Pulmonary Location History and Symptoms
Tuberculous Lymphadenitis Fever, painless lymph node swelling.
Skeletal Tuberculosis Low back pain, stiffness, joint swelling, limited mobility, pain in the affected joint or extremity.
Central Nervous System Tuberculosis Headache, seizures, weakness, vomiting.
Tuberculous Peritonitis Abdominal pain, fever, ascites
Tuberculous Pericarditis Shortness of breath, chest pain, cough, pedal edema.
Renal Tuberculosis Symptoms of UTI, such as polyuria, dysuria, hematuria, flank pain
Symptoms of obstructive uropathy, such as oliguria or anuria, pelvic pain.
Adapted from Asian Spine J. Feb 2014; 8(1): 97–111[3]; Handbook of Clinical Neurology[4]Circulation Dec 2005 vol.112 no.23 3608-3616[5]; Am J Trop Med Hyg 2013 vol. 88 no. 1 54-64[6]; Clin Infect Dis.(2011)53(6):555-562.[7]


References

  1. Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.
  2. Centers for Disease Control and Prevention (CDC), Division of Tuberculosis Elimination. Core Curriculum on Tuberculosis: What the Clinician Should Know. 4th edition (2000). Updated Aug 2003.
  3. Moon, Myung-Sang (2014). "Tuberculosis of Spine: Current Views in Diagnosis and Management". Asian Spine Journal. 8 (1): 97. doi:10.4184/asj.2014.8.1.97. ISSN 1976-1902.
  4. Garcia-Monco, Juan Carlos (2014). "Tuberculosis". 121: 1485–1499. doi:10.1016/B978-0-7020-4088-7.00100-0. ISSN 0072-9752.
  5. Mayosi, B. M. (2005). "Tuberculous Pericarditis". Circulation. 112 (23): 3608–3616. doi:10.1161/CIRCULATIONAHA.105.543066. ISSN 0009-7322.
  6. Daher, E. D. F.; da Silva Junior, G. B.; Barros, E. J. G. (2013). "Renal Tuberculosis in the Modern Era". American Journal of Tropical Medicine and Hygiene. 88 (1): 54–64. doi:10.4269/ajtmh.2013.12-0413. ISSN 0002-9637.
  7. Fontanilla, J.-M.; Barnes, A.; von Reyn, C. F. (2011). "Current Diagnosis and Management of Peripheral Tuberculous Lymphadenitis". Clinical Infectious Diseases. 53 (6): 555–562. doi:10.1093/cid/cir454. ISSN 1058-4838.

Template:WH Template:WS